Regulation of [3H]dopamine release from mesolimbic and mesocortical areas of guinea pig brain by sigma receptors

Schizophrenia Research

Volumn 21, Issue 1, 1996, Pages 51-62

  Weatherspoon, John K ^a   Gonzalez Alvear, Grace M ^a   Frank, Alison R ^a   Werling, Linda L ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

(+)Pentazocine; BD737; Dopamine; Nucleus accumbens; Prefrontal cortex; Sigma

Indexed keywords

DESIPRAMINE; DIZOCILPINE; DOMPERIDONE; DOPAMINE; DOPAMINE RECEPTOR; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N [2 (3,4 DICHLOROPHENYL)ETHYL] N METHYL 2 (1 PYRROLIDINYL)CYCLOHEXYLAMINE; NALOXONE; NISOXETINE; NOMIFENSINE; PENTAZOCINE; PHENCYCLIDINE; SIGMA OPIATE RECEPTOR; UNCLASSIFIED DRUG; VANOXERINE; YOHIMBINE; ANALGESIC AGENT; CYCLOHEXYLAMINE DERIVATIVE; DOPAMINE RECEPTOR BLOCKING AGENT; N METHYLASPARTIC ACID; PYRROLIDINE DERIVATIVE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINE RELEASE; EXTRAPYRAMIDAL SYMPTOM; GUINEA PIG; LIMBIC CORTEX; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; ANALYSIS OF VARIANCE; ANIMAL; DRUG EFFECT; METABOLISM; PHYSIOLOGY; SCHIZOPHRENIA;

ANALGESICS; ANALYSIS OF VARIANCE; ANIMALS; CYCLOHEXYLAMINES; DOPAMINE; DOPAMINE ANTAGONISTS; GUINEA PIGS; HALOPERIDOL; N-METHYLASPARTATE; NUCLEUS ACCUMBENS; PENTAZOCINE; PREFRONTAL CORTEX; PYRROLIDINES; RECEPTORS, SIGMA; SCHIZOPHRENIA;

EID: 0030607989     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(96)00030-8     Document Type: Article

References (45)

1. 3H](+)-3-PPP labeled sigma binding sites. Eur. J. Pharmacol. 240, 243-250.
2. Bellville, J. and Forrest, W. (1967) Respiratory and subjective effects of d- and l-pentazocine. Clin. Pharmacol. Ther. 9, 142-153.
3. Bowen, W.D. et al. (1988) σ-receptors negatively modulate agonist-stimulated phosphoinositide metabolism in rat brain. Eur. J. Pharmacol. 149, 399-400.
4. Bowen, W.D. et al. (1992) Characterization of the enantiomers of cis-N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)cyclohexyl-amine (BD737 and BD738): novel compounds with high affinity, selectivity and biological efficacy at σ receptors. J. Pharmacol. Exp. Ther. 262, 32-40.
5. Ceci, A., Smith, M. and French, E.D. (1988) Activation of the A10 mesolimbic system by the sigma receptor agonist SKF10,047 can be blocked by rimcazole, a novel putative antipsychotic. Eur. J. Pharmacol. 154, 53-57.
6. 2 receptor in rat brain. Mol. Pharmacol. 42, 471-479.
7. Deutsch, S.I. et al. (1988) The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy. Clin. Neuropharmacol. 11, 105-106.
8. Engberg, G. and Wikstrom, H. (1991) Sigma receptors: implication for the control of neuronal activity of nigral dopamine-containing neurons. Eur. J. Pharmacol. 201, 199-202.
9. Galloway, M.P., Wolf, M.E. and Roth, R.H. (1986) Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo. J Pharmacol. Exp. Ther. 236, 689-698.
10. Goldstein, S.R. et al. (1989) Motor effects of two σ ligands mediated by nigrostriatal dopmine systems. Synapse 4, 254-258.
11. 3H]dopamine release from rat striatal slices by sigma receptor ligands. J. Pharmacol. Exp. Ther. 271, 212-219.
12. Gonzalez-Alvear, G.M. and Werling, L.L. (1995a) Sigma receptor regulation of norepinephrine release from rat hippocampal slices. Brain Res. 673, 61-69.
13. 3H] dopamine release via a presynaptic mechanism. Eur. J. Pharmacol. 294, 713-719.
14. Gonzalez-Alvear, G.M. et al. (1995) Functional and binding properties of σ receptors in rat cerebellum. J. Neurochem. 65, 2509-2516.
15. Grace, A.A. (1991) The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. J. Neural Transm. 36 (Suppl.), 91-131.
16. 3H-hydroxylphenyl)-N-(1-propyl)-piperidme. J. Neurosci. 6, 1757-1770.
17. Itzhak, Y. and Stein, I. (1991) Regulation of σ-receptors and responsiveness to guanyl nucleotides following repeated exposure of rats to haloperidol: further evidence for multiple σ binding sites. Brain Res. 566, 166-172.
18. Iyengar, S. et al. (1990) σ receptors modulate both A9 and A10 dopaminergic neurons in rat brain: functional interaction with NMDA receptors. Brain Res. 524, 322-326.
19. Izenwasser, S., Werling, L.L. and Cox, B.M. (1990) Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex. Brain Res. 520, 303-309.
20. Karbon, E.W. et al. (1993) NPC 16377, a potent and selective σ-ligand. I. Receptor binding, neurochemical and neuroendocrine profile. J. Pharmacol. Exp. Ther. 265, 866-875.
21. Krebs, M.O. et al. (1991) Glutamatergic control of dopamine release in the rat striatum: Evidence for presynaptic N-methyl-D-aspartate receptors on dopaminergic nerve terminals. J. Neurochem. 50, 81-85.
22. Largent, B.L. et al. (1988) Novel antipsychotic drugs share high affinity at σ receptors. Eur. J. Pharmacol. 155, 345-347.
23. Leitner, M.L. et al. (1994) Regional variation in the ratio of sigma-1 to sigma-2 binding in rat brain. Eur. J. Pharmacol. 259, 65-69.
24. Martin, W.R. et al. (1976) The effects of morphine- and nalorphine-like drugs in the non-dependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517-532.
25. Mash, D.C. and Zabetian, C.P. (1992) Sigma receptors are associated with cortical limbic areas in the primate brain. Synapse 12, 195-205.
26. Matsuno, K. et al. (1993) Increase in extracellular acetylcholine level by σ ligands in rat frontal cortex. J. Pharmacol. Exp. Ther. 265, 851-859.
27. McLean, S. and Weber, E. (1988) Autoradiographic visualization of haloperidol sensitive sigma receptors in guinea pig brain. Neuroscience 25, 259-269.
28. Peterson, G.L. (1977) A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346-356.
29. Pozzi, L. et al. (1994) Evidence that extracellular concentrations of dopamine are regulated by noradrenergic neurons in the frontal cortex of rats. J. Neurochem. 63(1), 195-200.
30. Quirion, R. et al. (1992) A proposal for the classification of σ sites. Trends Pharmacol. Sci. 13, 85-86.
31. Rothman, R.B. et al. (1990) Interaction of calcium channel blockers with multiple σ binding sites in guinea pig brain. In: Proceedings on the Committee on Drug Dependence, NIDA Monograph Series, Rockville, MD, pp. 322-328.
32. Rückert, N.G.H. and Schmidt, W.J. (1993) The σ receptor ligand 1,3-di-(tolyl)guanidine in animal models of schizophrenia. Eur. J. Pharmacol. 233, 261-267.
33. Shibuya, H., Mori, H. And Toru, M. (1992) Sigma receptors in schizophrenic cerebral cortices. Neurochem. Res. 17, 983-990.
34. Tam, S.W. (1983) Naloxone-inaccessible σ receptor in rat central nervous system. Proc. Natl. Acad. Sci. USA 80, 6703-6707.
35. 3H]haloperidol binding in guinea pig membranes. Proc. Natl. Acad Sci. USA 81, 5618-5621.
36. Tam, S.W. and Zhang, A.-Z. (1988) σ and PCP receptors in human frontal cortex membranes. Eur. J. Pharmacol. 154, 343-344.
37. 2 receptor antagonist: receptor-binding, electrophysiological and neuropharmacological profiles. J. Pharmacol. Exp. Ther. 263, 1167-1174.
38. Taylor, D.P. and Dekleva, J. (1987) BMY14,802: A potential antipsychotic agent that selectively binds to sigma receptors. In: E.F. Domino and J.M. Kamenka (Eds.), Sigma and Phencyclidine-like Compounds as Molecular Probes in Biology. NPP Books, Ann Arbor, pp. 345-355.
39. Van Rossum, J.M. et al. (1970) The neuroleptics. In: D.P. Bobon, P.A.J. Janssen and J. Bobon (Eds.), Mod. Probl. Pharmacopsychiatry, Vol. 5. Karger, Basel/Munchen, Paris, New York, pp. 23.
40. Walker, J.M. et al. (1990) Sigma receptors: biology and function. Pharmacol. Rev. 42, 355-402.
41. Weinberger, D.R., Berman, K.F. and Daniel, D.G. (1992) Mesoprefrontal cortical dopaminergic activity and prefrontal hypofunction in schizophrenia. Clin. Neuropharmacol. 15 (Suppl. 1), 568A-569A.
42. Weissman, A.D. et al. (1988) Sigma receptors in post-mortem human brain. J. Pharmacol. Exp. Ther. 247, 29-33.
43. Weissman, A.D. et al. (1991) Selective loss of cerebral cortical σ, but not PCP binding sites in schizophrenia. Biol. Psychiatry 29, 41-54.
44. Werling, L.L. et al. (1988) Kappa receptor regulation of dopamine release from striatum and cortex of rats and guinea pigs. J. Pharmacol. Exp. Ther. 246, 282-286.
45. 3H]dopamine release from guinea pig striatum by NMDA receptor/channel activators and inhibitors. J. Pharmacol. Exp. Ther. 255, 40-45.